Acumen Pharmaceuticals
(NASDAQ) ABOS
Acumen Pharmaceuticals Financials at a Glance
Market Cap
$154.46M
Revenue (TTM)
$90.00K
Net Income (TTM)
$121.33M
EPS (TTM)
$-2.00
P/E Ratio
-1.16
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.26
Volume
40,823
Open
$2.52
Price
$2.26
Volume
40,823
Open
$2.52
Previous Close
$2.26
Daily Range
$2.25 - $2.52
52-Week Range
$0.86 - $3.60
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.26
Volume
40,823
Open
$2.52
Previous Close
$2.26
Daily Range
$2.25 - $2.52
52-Week Range
$0.86 - $3.60
ABOS News
ABOS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acumen Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
61
CEO
Daniel J. O'Connell, MBA
Website
www.acumenpharm.comHeadquarters
Newton, VA 22902, US
ABOS Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
1376%
Net Income Margin
1348%
Return on Equity
-96%
Return on Capital
-1%
Return on Assets
-99%
Earnings Yield
-86.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$154.46M
Shares Outstanding
60.57M
Volume
40.82K
Short Interest
0.00%
Avg. Volume
828.61K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$123.83M
EBITDA
$123.83M
Operating Cash Flow
$115.54M
Capital Expenditure
$88.00K
Free Cash Flow
$115.63M
Cash & ST Invst.
$116.86M
Total Debt
$8.77M
Acumen Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$90.00K
N/A
Gross Profit
$45.00K
-2.3%
Gross Margin
50.00%
N/A
Market Cap
$154.46M
N/A
Market Cap/Employee
$2.53M
N/A
Employees
61
N/A
Net Income
$25.14M
+32.3%
EBITDA
$25.11M
+30.4%
Quarterly Fundamentals
Net Cash
$108.10M
-23.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$8.77M
+6490.2%
Return on Assets
-98.78%
N/A
Return on Invested Capital
-1.33%
N/A
Free Cash Flow
$19.10M
+29.8%
Operating Cash Flow
$19.10M
+29.8%